Jump Financial’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Jump Financial’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-525	Closed	-$4.51K	–	2382
2024 Q1	$4.51K	Buy	+525	New	+$2.51K	﹤0.01%	1848
2021 Q1	–	Sell	-751	Closed	-$176K	–	1372
2020 Q4	$176K	Buy	+751	New	+$105K	0.03%	801

Other funds holding TCON

GPFA

Game Plan Financial Advisors Westlake, Ohio $222M AUM 22.82% 1-Year Est. Return

Jump Financial's TCON Position: Q2 2024 in Review

Jump Financial sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2024, closing a stake of 525 shares — an estimated $4.51K sold.

Jump Financial first reported a position in TCON in Q4 2020 and held it in 2 quarters. The position peaked at $176K in Q4 2020. 1 fund tracked by Wall St. Rank holds TCON as of Q2 2024.

Jump Financial reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Jump Financial sold 525 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $4.51K.
Jump Financial first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
Jump Financial's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $176K in Q4 2020.
1 fund tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Jump Financial's 13F filing for Q2 2024, filed 14 Aug 2024.